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Objective: The conventional technique of laparoscopic myomectomy (LM) was performed by complete
enucleation of the myoma followed by morcellation as described previously. However, the conventional
technique of LM presented some inherent problems in the management of larger myomas. Our objective
was to compare the surgical outcome of the semisimultaneous morcellation in situ (SSMI group) tech-
nique and conventional morcellation (Control group).
Materials and methods: In this prospective caseecontrol study 122 patients with symptomatic uterine
myomas treated with LM were recruited and divided into two groups. Patients in the Control group
underwent LM using the conventional technique of completely enucleating the myoma followed by
morcellation. In the SSMI group, morcellation was initiated from the upper half of the myoma and then
the lower half was completely enucleated.
Results: Fifty-four women underwent SSMI, and 68 women served as controls. There was no difference
in the baseline characteristics between the two groups. The SSMI technique signiﬁcantly reduced surgical
time (163.2 ± 46.8 minutes vs. 189.4 ± 56.7 minutes; p ¼ 0.007), although the difference in the mean
blood loss was not signiﬁcant (178 ± 147 mL vs. 203 ± 185 mL; p ¼ 0.417), compared with the control.
Furthermore, SSMI technique and myoma weight contributed to longer surgical times in multivariate
analysis.
Conclusion: The SSMI technique could shorten surgical time when a laparoscopic myomectomy is per-
formed, but uterine size is also important.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Laparoscopic myomectomy (LM) is one of the powerful surgical
procedures for the treatment of uterine leiomyoma. Laparoscopic
myomectomy is more advantageous than abdominal myomectomy
with less postoperative pain, a shorter hospital stay and less post-
operative adhesions.1e5 However, LM is more technical, especiallyof interest.
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.
for Gynecologic Endoscopy and Minimwhile dealing with the larger myomas.6e8 In a limited space, the
large dimension of the myoma makes the enucleation with the
laparoscopy far more difﬁcult.9,10 It not only takes time, but also
increases blood loss. Therefore, it is necessary to modify the LM
technique, especially while dealing with the larger myomas.
The conventional technique of LM was performed by complete
enucleation of the myoma ﬁrst, followed by morcellation, which
was pioneered by Kurt Semm in 1973.11e13 Simultaneous morcel-
lation in situ (SMI), a modiﬁed method proposed in recent studies,
leveraged the morcellator to enucleate the myoma down to its base
by performing morcellation directly on the uterine surface without
prior enucleation (i.e., simultaneous enucleation and morcellation
of the myoma in situ).14 Although the SMI technique signiﬁcantlyally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1. Illustration of laparoscopic myomectomy with semisimultaneous morcella-
tion in situ in three steps. Step 1: (A) Identiﬁcation of location of intramural myoma. (B)
Enucleation of the upper one half of the myoma by morcellation. Step 2: (C and D)
Enucleation of the lower half of the myoma from its attachment to the myometrium by
sharp dissection. Step 3: (E and F) Reapproximation of myometrial edges with inter-
rupted ﬁgure-of-8 sutures and then morcellation of the enucleated lower half of the
myoma.
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inadvertent penetration of the endometrium with the morcellator,
which has been a concern, especially in large, deep intramural
myomas.15,16 Furthermore, blood loss was slightly higher in the SMI
group compared to the conventional LM group in previous
studies.14,15
To avoid the risk of endometrial penetration, we modiﬁed the
SMI technique and called it semisimultaneous morcellation in situ
(SSMI). We performed the morcellation toward the upper half of
the myoma ﬁrst and enucleated the lower half of the myoma, fol-
lowed by suture of the myometrial edges, and ending with the
morcellation of the remaining myoma. We hypothesized that the
SSMI technique would have a shorter surgical time without an in-
crease in blood loss and also reduce the risk of endometrial pene-
tration as compared to the conventional LM group.
Our objective was to compare the surgical outcome of the SSMI
technique and conventional LM.
Materials and methods
Patients
This studywas designed as a cohort study. The participants were
recruited at a tertiary medical center in northern Taiwan from
January 2009 through to June 2010. Approval for the study was
obtained from the Taipei Veterans General Hospital's ethics com-
mittee, and informed consent was obtained from all patients
(Veterans General Hospital Institutional Review Board (VGHIRB)
No.: 98-01-20A; Clinical Trial Registration: NCT00860002). Based
on a previous study of surgical time and our preliminary data for
the SSMI operative time, we used mean ± standard deviation (SD)
for the SSMI and conventional groups, respectively, as the primary
criterion in our power analysis (p ¼ 0.85, a ¼ 0.05, equal sizes for
both groups and a two-tailed test) to calculate a minimum sample
size of 50 patients for each group. Assuming a 10% dropout rate, the
trial protocol speciﬁed a sample of patients.
A total of 132 patients scheduled for elective LM were screened
in this study. The inclusion criteria were female, aged 30e45 years,
and an American Society of Anesthesiologists physical status clas-
siﬁcation of I or II. Only intramural-type myomas >3 cm in diam-
eter, as measured by ultrasound, were included in the study.
Patients were excluded if their disease was malignant, if they
needed additional adnexal surgery (n¼ 8) or if they were unwilling
to participate (n ¼ 2). Finally, data for 122 patients were analyzed.
All the patients received routine preoperative preparation, which
included the taking of a full history, a clinical examination, and
laboratory testing. A review of the LM surgical records was per-
formed, and the study population was classiﬁed into two groups:
conventional LM (n ¼ 68) was performed in the ﬁrst 11 months of
the study (JanuaryeNovember 2009), and the SSMI technique
(n ¼ 54) was applied in all cases after December 2009 (December
2009eJune 2010).
All procedures were performed by a single surgeon at a single
institute during the study period. The surgeon is familiar with LM
surgery and since January 2007 has performed >300 cases. The
postoperative assessment was performed by independent
investigators.
Surgical procedures
All surgical procedures were performed under general endo-
tracheal anesthesia with the patient in the Trendelenburg position
and the bladder catheterized. The Kronner uterine manipulator
(Kronner Medical Manufacturing, Roseburg, Oregon, USA) was
inserted through the cervix and into the uterus.SSMI group
Pneumoperitoneum by insufﬂation with carbon dioxide was
established either with the use of a Veress needle, for patients
without prior surgery, or by the open method with a 1.2-cm um-
bilical incision, for patients with history of surgery. A primary 10-
mm trocar was inserted through the umbilicus to introduce the
videolaparoscopic system (Karl Storz). Three other accessory 0.5-
cm trocars were inserted; two were 2 cm above the ante-
rosuperior iliac spines and lateral to the rectus abdominis muscle,
and the third was placed at the suprapubic area, to facilitate
insertion of laparoscopic operative instruments. A panoramic 360
evaluation of the pelvis was performed to check for adhesions and
other pelvic pathology, which could complicate the procedure.
Vasoconstrictive solution (vasopressin 20 m/mL diluted in 60 mL of
saline solution) was injected at various points over the dome of the
uterus and at the uterine attachment to the myoma. The left lower
quadrant port was then converted to a 1.2-cm incision for insertion
of the morcellator (Karl Storz). The SSMI group underwent three
steps: (1) the upper half of the myoma was enucleated by mor-
cellation (Figure 1AeC); (2) the residual lower half was enucleated
by sharp dissection down to the myoma base (Figure 1D); and (3)
myometrial edges were reapproximated in two layers with inter-
rupted ﬁgure-of-8 intracorporeal knots (Polysorb 0) prior to mor-
cellation of the isolated lower half of the myoma (Figure 1E and F).
Hemostasis was assured. A closed wound vacuum reservoir (CWV)
drain was inserted and placed in the cul-de-sac. The 1.2-cm
abdominal incisions were closed in two layers (Polysorb 2-0,
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(Ethicon Inc., Johnson & Johnson Co.)Control group (conventional morcellation)
The trocar insertion was the same as that in the SSMI group.
Then, we enucleated the entiremyoma. Themyometrial edgeswere
sutured in two layers, with interrupted ﬁgure-of-8 intracorporeal
knots (Polysorb 0). Hemostasis was assured. The enucleated my-
oma was then removed by morcellation. A CWV drain was inserted
and placed in the cul-de-sac. The 1.2-cm abdominal incisions were
closed in two layers (Polysorb 2-0, Dexon 3-0), and the 0.5-cm in-
cisions were closed with Dermabond (Ethicon Inc., Johnson &
Johnson Co.)Evaluation parameters
The parameters, which were considered to compare both
groups, were myoma character (size, location, weight, and num-
ber), surgical parameters, and morbidity. The surgical parameters
included surgical time (minutes), estimated blood loss (mL), and
time of removal of CWV drain (days). Morbidity included per-
centage of blood transfusion, ileus, uterine hematoma, and intes-
tinal serosal tears. Patient discomfort consisted of ﬂatus day (time
of return of gastrointestinal function), postoperative use of anal-
gesia (accumulative dosage of meperidine hydrochloride), and
length of hospital stay (days). The cost of hospitalization of the two
groups was also compared.Statistical analysis
Statistical software (SPSS, version 17.0; SPSS Inc., Chicago, IL,
USA) was used to analyze all the data. Data are presented as the
mean ± standard deviation (SD) and n (%). The parametric-
independent sample t test was used to compare the differences
between the two groups. Fisher's exact test and x2 analysis were
used for categorical variables. For all statistical evaluations, p < 0.05
was used to reject the null hypothesis. Multivariate analysis was
performed using linear regression. The outcome variable for these
analyses was surgical time. The study group, Body Mass Index
(BMI), and myoma characteristics (location, weight, and number)
were used as covariates.Results
Demographic parameters, including age, BMI, previous surgical
history, and myoma largest diameter, number, and location, were
comparable between the two groups (Table 1). There were no sig-
niﬁcant differences among these variables (Table 1). None of the
patients was converted to laparotomy in either group.
Surgical outcomes are shown in Table 2. The myoma weight,
surgical blood loss, drain removal time, total mepridine HCl dose,
time to ﬁrst ﬂatus, and length of postoperative hospital stay
showed no signiﬁcant difference between the two groups.
Furthermore, SSMI did not increase the incidence of inadvertent
penetration of the endometrium (SSMI group vs. control group:
1.9% vs. 2.9%, p ¼ 1.000). Blood loss in the two group was also no
difference (SSMI group vs. control group: 178 ± 147 mL vs.
203 ± 185 mL, p¼ 0.417).The only statistically signiﬁcant difference
in the clinical characteristics between the two groups was surgical
time. Surgical time in the SSMI group was shorter than that in the
control group (163.2 ± 46.8 minutes vs. 189.4 ± 56.7 minutes;
p ¼ 0.007; Table 2).Upon analysis of multiple predictive factors affecting surgical
time, it was noted that the SSMI technique andmyomaweight were
major predictive factors affecting surgical time (Table 3).
Neither group had intraoperative complications, nor was there a
difference in the rate of perioperative complications between the
two groups (7.4% vs. 13.2%, p ¼ 0.300; Table 4). There were three
cases (5.5%) of postoperative anemia in the SSMI group and eight
cases (11.8%) in the control group with p ¼ 0.343. Other post-
operative complications in the SSMI group were one case of ileus
(1.8%) and one case of intestinal serosal tear (1.8%). There was one
case of postoperative uterine hematoma (1.8%) in the conventional
group.
The case of ileus in the SSMI group was managed with naso-
gastric decompression. She had a return of normal gastrointestinal
function at the 4th postoperative day. The case of intestinal serosal
tearing in the SSMI group was not caused by morcellation; rather it
was secondary to adhesiolysis of severe pelvic endometrial adhe-
sions between the colon and the posterior uterinewall and bilateral
adnexae. The intestinal serosal tear was sutured laparoscopically.
The presence of ﬂatus was achieved on the 1st postoperative day,
and the patient was asymptomatic when she went home on the 3rd
postoperative day. The case of postoperative uterine hematoma in
the conventional group, measuring 1.5 cm, had a preoperative
solitary 10.8-cm anterofundal, intramural myoma with a subserous
component. It was observed and managed conservatively with
tranexamic acid. The uterine hematoma was resolved on repeat
transvaginal ultrasound 1 month from the surgical procedure.
Discussion
Our study showed the advantage of the SSMI technique with a
shorter surgical time and the better adroit manipulation. The
conventional technique separates the myoma completely from the
uterus before morcellation,12 so there is limited space available for
the pushepull maneuvers.17 Additionally, traction by a myoma
screw or grasper may not be adequate or efﬁcient and repeat
repositioning of the screw is required in the conventional tech-
nique, which may be very cumbersome.18 Our technique offers
certain advantages that help to overcome these problems. First, the
combination of enucleation and morcellation for the upper half of
the myoma is less demanding for the operator (Figure 1B). Second,
morcellation created more space for a better view and optimum
movement of instruments (Figure 1C). Third, enucleation of the
lower half of the myoma became easier and faster because the
initial morcellation of the upper half of the myoma provides more
space for maneuverability of instruments, similar to in situ mor-
cellation14 (Figure 1D). Therefore, the SSMI technique could reduce
surgical time and is an efﬁcient alternative LM technique.
Another major concern regarding the efﬁcacy of this technique
concerns hemostasis. Myomas have a relatively hypovascular cen-
ter but are surrounded by a rich periﬁbroid arterial plexus.19 Sinha
et al20 reported that in their study of enucleation bymorcellation of
myomata while still attached to the uterus, the SMI group had a
mean blood loss of 284 ± 229 mL vs. 219 ± 111 mL in the conven-
tional LM group. In another SMI study by Torng et al,15 the mean
blood loss of the SMI group was 138 ± 172 mL vs. 93 ± 82 mL in the
conventional LM group (p < 0.001). Both studies documented
higher blood loss in the SMI group when compared to the con-
ventional group. Less blood loss with the SSMI technique in our
studymay be attributed to four factors: (1) the lower half of myoma
is smaller in size after the SSMI procedure, providingmore space for
maneuverability of instruments similar to in situ morcellation,14
which may help to coagulate the feeding vessels of myomata at-
tachments to the myometrium during enucleation (Figure 1B and
C); (2) repeated repositioning of the screw is not required during
Table 1
Demographic data and surgical variables in semisimultaneous morcellation in situ and conventional laparoscopic myomectomy.
Basic data SSMI group n ¼ 54 Control group n ¼ 68 p 95% conﬁdence interval
Age (y) 39.20 ± 6.02 40.12 ± 7.36 0.463a 0.914 (3.370e1.542)
BMI (kg/m2) 23.97 ± 2.26 24.07 ± 1.94 0.808a 0.381 (0.847e0.662)
Myoma number 1.83 ± 1.06 2.09 ± 1.52 0.298a 0.255 (0.738e0.228)
Maximum diameter (cm) 6.53 ± 2.43 6.22 ± 1.96 0.439b 0.309 (0.479e1.097)
History of abdominal surgery 11 (20.4) 17 (25) 0.546b 0.859 (0.516e1.431)
Location of myoma
Anterofundal 33 (61.1) 38 (55.9) 0.561b 1.129 (0.747e1.705)
Posterior 21 (38.8) 30 (44.1) 0.561b 0.886 (0.587e1.338)
Data are presented as n (%) or mean ± standard deviation.
*p < 0.05 is statistically signiﬁcant.
CI ¼ conﬁdence interval; SSMI ¼ semisimultaneous morcellation in situ.
a t-test: mean difference; mean difference (95% CI).
b Chi-square test or Fisher's exact test: relative risk (95% CI).
Table 2
Comparison of surgical results between semisimultaneous morcellation in situ and conventional laparoscopic myomectomy.
Basic data SSMI group n ¼ 54 Control group n ¼ 68 p 95% conﬁdence interval
Myoma weight (g) 160.83 ± 156.23 159.87 ± 148.33 0.972a 0.966 (53.844e55.776)
Surgical time (min) 163.15 ± 46.82 189.41 ± 56.69 0.007a,* 26.264 (45.235e7.293)
Blood loss (mL) 177.78 ± 147.40 202.94 ± 185.07 0.417a 25.163 (86.325e35.998)
CWV drain removed (d) 2.30 ± 0.57 2.28 ± 0.75 0.891a 0.017 (0.227e0.261)
Total meperidine HCl dose (mg) 69.63 ± 31.26 70.00 ± 22.26 0.939a 0.370 (9.975e9.234)
Flatus (d) 1.26 ± 0.55 1.19 ± 0.39 0.432a 0.068 (0.103e0.239)
Hospital stay (d) 4.35 ± 0.61 4.32 ± 0.96 0.852a 0.028 (0.272e0.329)
Blood transfusion 3 (5.6) 8 (11.8) 0.343b 0.594 (0.221e1.591)
Penetration of the endometrium 1 (1.9) 2(2.9%) 1.000 0.623 (0.055e7.055)
Data are presented as n (%) or mean ± standard deviation.
*p < 0.05 is statistically signiﬁcant.
CWV ¼ closed wound vacuum reservoir; SSMI ¼ semisimultaneous morcellation in situ.
a t-test: mean difference; mean difference (95% conﬁdence interval).
b Chi-square test or Fisher's exact test: relative risk (95% conﬁdence interval).
Table 3
Correlation of laparoscopic myomectomy surgical procedure, body mass index,
history of previous surgery, and myoma character with surgical time (minutes) after
multiple regression.
Factors Regression coefﬁcient Standard error p
SSMI 25.102 8.358 0.003*
BMI 2.252 1.522 0.142
Posterior location 5.057 4.345 0.247
Myoma number 2.621 3.168 0.410
Myoma weight 0.172 0.028 <0.001*
*p < 0.05 is statistically signiﬁcant.
BMI ¼ body mass index; SSMI ¼ semisimultaneous morcellation in situ.
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trolling bleeding caused by the screws; (3) rapid homeostasis with
immediate suture reapproximation of the myometrium before
performing morcellation evacuation of the enucleated lower half of
the myoma (Figure 1E); and (4) the SSMI technique further short-
ened the surgical time; this alone could decrease bleeding time.Table 4
Complications.
Complications SSMI group n ¼ 54 Contro
Total cases 4 (7.4) 9 (13.2
Postop anemia 3 (5.5) 8 (11.8
Uterine hematoma 0 1 (1.5)
Ileus 1 (1.8) 0
Intestinal serosal tear 1 (1.8) 0
Data are presented as n (%).
*p < 0.05 is statistically signiﬁcant.
CI ¼ conﬁdence interval; RR ¼ relative risk; SSMI ¼ semisimultaneous morcellation in s
a Chi-square test or Fisher's exact test: relative risk (95% CI).Our experience has been encouraging. The mean blood loss was
lower in the SSMI group compared to the conventional group.
This SSMI technique compares very favorably with the con-
ventional technique with regard to endometrial penetration. In
SMI, one other problem that could arise is in the case of large or
deep intramural myomas extending down to the endometrium.21
The traction force exerted by the morcellator could cause the
endometrium to be pulled up alongwith themyoma, and this could
result in the inadvertent morcellation of the endometrium along
with the myoma.14,15 However, in our modiﬁed procedure (SSMI),
the endometrium can easily be distinguished from the residual
myoma. When the endometrium is pulled, it can be separated from
themyoma. Themeticulous dissection of the myoma base using the
SSMI technique provides safe anatomic exposure, which will help
to easily distinguish endometrium from the residual myoma and
avoid inadvertent morcellation of the endometrium.
There were four cases (7.4%) of complication in the SSMI group
andnine cases (13.2%) in the conventional groupwith p¼ 0.300. The
complication rate of SSMI in this study, including one postoperative
ileus that required additional hospitalization days without surgicall group n ¼ 68 p RR (95% CI)
) 0.300a 0.671 (0.289e1.555)
)
itu.
H.-W. Tsai et al. / Gynecology and Minimally Invasive Therapy 4 (2015) 132e136136intervention and three episodes of intraoperative bleeding (ranging
from500mL to 900mL) that required blood transfusion,was similar
to other LM studies.15,22 However, because SSMI appeared to be
much easier, especially when larger or multiple myomas were
encountered, further LMwithout using SSMI seems impractical. Our
result reported a 26-minute surgical time difference in favor of SSMI
comparedwith conventional LM. Although the rate of conversion to
laparotomy in LM has been reportedly as high as 28% in other
studies,23 all patients were successfully treated with LM in our
current study. Possible explanations for this difference include the
selection of the patients and experiences of the physicians. This
confounding factor of patient selection for laparoscopic myomec-
tomy could be accommodated by regression analysis to incorporate
all factors, such as total myoma weight, number of myomas surgi-
cally treated, and BMI. Therefore, our results agree with most other
reports that SSMI is a safe procedure for LM and the advantage of
SSMI is more apparent for the larger myoma.
This study methodology has limitations. The SSMI technique
was introduced in the last year of the surgery, and the analysis of its
superiority was performed at the end of the surgeon's learning
curve. Still, the experienced surgeon had completed >300 cases of
LM before the study. Because this study is a cohort study, random
classiﬁcation of cases was not performed.
In conclusion, this study suggests that the SSMI surgical technique
could shorten surgical time. The estimated blood loss is similar as
compared with the conventional LM. Therefore, SSMI is a safe and
efﬁcient alternative LM technique for symptomatic myomas.Acknowledgments
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